mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.2 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.2 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.2 |